Related by context. Frequent words. (Click for all words.) 60 CytoFab 60 Phase IIb clinical trials 58 deforolimus 58 pancreatic insufficiency 58 Ketotransdel 57 Mipomersen 57 Diamyd ® 57 Prestara 56 eprotirome 56 phase IIa clinical 56 GV# [001] 56 TNF blocker 56 GRNCM1 56 phase 2a 56 Canvaxin 56 TH# [003] 56 Desmoteplase 55 Roflumilast 55 liprotamase 55 gets USFDA nod 55 SEPET TM 55 cinacalcet 55 Phase Ib II 55 ThermoDox R 55 Initiate Phase 55 muraglitazar 55 otelixizumab 54 recurrent glioblastoma multiforme 54 preclinical efficacy 54 placebo controlled clinical 54 orBec 54 Edurant 54 MYDICAR 54 Chronic Heart Failure 54 phase IIb clinical 54 Phase Ib clinical 53 PD LID 53 Ixempra 53 Hepatitis C HCV 53 senicapoc 53 multiple myeloma MM 53 Acute Ischemic Stroke 53 tesofensine 53 exocrine pancreatic insufficiency 53 Aliskiren 53 rFVIIa 53 REGN# 52 Cerovive 52 Acapodene 52 olmesartan 52 gastrointestinal mucositis 52 Asentar 52 phase IIa 52 GRNVAC1 52 Trofex 52 Urocidin 52 pamidronate 52 Pirfenidone 52 ProSavin 52 motesanib 52 acute coronary syndromes ACS 52 multicentre study 51 midstage clinical trial 51 teplizumab 51 PROSTVAC TM 51 Retisert 51 neuroprotectant 51 chronic obstructive lung 51 almorexant 51 Paion 51 Dendreon Provenge 51 ICA # 51 Nuvion 51 Myfortic 51 TSX COM 51 ongoing Phase 1b 51 MERLIN TIMI 51 Phase IIb trials 51 isavuconazole 51 rolofylline 51 Fablyn 51 ocrelizumab 50 CONCERTA 50 anti arrhythmic 50 non valvular atrial 50 efficacy tolerability 50 darusentan 50 tanespimycin 50 QTinno 50 phase Ib 50 Hydroxyurea 50 Phase IIb clinical 50 motavizumab 50 multicenter prospective 49 efficacy endpoint 49 QLT# 49 Response Biomedical Corporation 49 peripheral arterial 49 Bifeprunox 49 Levadex 49 Photocure